Stimulated by our ongoing uncertainty about which unruptured cerebral aneurysms to treat brought about by a near-complete lack of meaningful clinical trial data, facilitated by substantial increases in computing power, and promulgated by scientists and engineers facile in generating massive amounts
No takes yet. Share an insight, caveat, or question.
David F. Kallmes (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: